Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

July 01, 1996; Volume 50,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ahluwalia, G S

    1. You have access
      2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
      G S Ahluwalia, W Y Gao, H Mitsuya and D G Johns
      Molecular Pharmacology July 1996, 50 (1) 160-165;
  2. Akerman, G

    1. You have access
      Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;
  3. Almaula, N

    1. You have access
      Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
      N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
      Molecular Pharmacology July 1996, 50 (1) 34-42;
  4. Angelotti, T P

    1. You have access
      Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
      Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 185-195;

B

  1. Baker, S P

    1. You have access
      A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;
  2. Ballesteros, J A

    1. You have access
      Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
      N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
      Molecular Pharmacology July 1996, 50 (1) 34-42;
  3. Barone, L

    1. You have access
      Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;
  4. Barwick, J L

    1. You have access
      Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;
  5. Bayard, F

    1. You have access
      Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
      F Mesange, F Delarue, J Puel, F Bayard and J C Faye
      Molecular Pharmacology July 1996, 50 (1) 75-79;
  6. Beavers, L

    1. You have access
      Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;
  7. Behrends, S

    1. You have access
      Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
      A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
      Molecular Pharmacology July 1996, 50 (1) 1-5;
  8. Belardinelli, L

    1. You have access
      A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;
  9. Bhattacharya, S

    1. You have access
      Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors.
      S Bhattacharya and J Linden
      Molecular Pharmacology July 1996, 50 (1) 104-111;
  10. Boissard, C G

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;
  11. Browning, M D

    1. You have access
      Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
      Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 185-195;
  12. Bruno, V

    1. You have access
      (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
      C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
      Molecular Pharmacology July 1996, 50 (1) 6-9;
  13. Burgard, E C

    1. You have access
      Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
      E C Burgard, E I Tietz, T R Neelands and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 119-127;

C

  1. Canonico, P L

    1. You have access
      Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;
  2. Cavallaro, S

    1. You have access
      Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;
  3. Chance, R E

    1. You have access
      Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;
  4. Chavkin, C

    1. You have access
      k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release.
      M L Simmons and C Chavkin
      Molecular Pharmacology July 1996, 50 (1) 80-85;
  5. Cheng, E

    1. You have access
      Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
      N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
      Molecular Pharmacology July 1996, 50 (1) 140-148;
  6. Cline, R T

    1. You have access
      Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
      N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
      Molecular Pharmacology July 1996, 50 (1) 140-148;
  7. Copani, A

    1. You have access
      Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;
  8. Criscimagna, N L

    1. You have access
      B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells.
      S A Mathis, N L Criscimagna and L M Leeb-Lundberg
      Molecular Pharmacology July 1996, 50 (1) 128-139;

D

  1. D'Agata, V

    1. You have access
      Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;
  2. Delarue, F

    1. You have access
      Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
      F Mesange, F Delarue, J Puel, F Bayard and J C Faye
      Molecular Pharmacology July 1996, 50 (1) 75-79;
  3. Dubocovich, M L

    1. You have access
      Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
      P A Witt-Enderby and M L Dubocovich
      Molecular Pharmacology July 1996, 50 (1) 166-174;
  4. Dudek, E M

    1. You have access
      Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
      Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 185-195;
  5. Dworetzky, S I

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

E

  1. Ebersole, B J

    1. You have access
      Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
      N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
      Molecular Pharmacology July 1996, 50 (1) 34-42;
  2. Esbenshade, T A

    1. You have access
      Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
      H Zhong, S W Guerrero, T A Esbenshade and K P Minneman
      Molecular Pharmacology July 1996, 50 (1) 175-184;

F

  1. Faye, J C

    1. You have access
      Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
      F Mesange, F Delarue, J Puel, F Bayard and J C Faye
      Molecular Pharmacology July 1996, 50 (1) 75-79;
  2. Fraser, C M

    1. You have access
      Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
      N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
      Molecular Pharmacology July 1996, 50 (1) 140-148;

G

  1. Gadski, R

    1. You have access
      Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;
  2. Gao, W Y

    1. You have access
      2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
      G S Ahluwalia, W Y Gao, H Mitsuya and D G Johns
      Molecular Pharmacology July 1996, 50 (1) 160-165;
  3. García-Sáinz, J A

    1. You have access
      Effect of phorbol myristate acetate on alpha 1-adrenergic action in cells expressing recombinant alpha 1-adrenoceptor subtypes.
      J Vázquez-Prado and J A García-Sáinz
      Molecular Pharmacology July 1996, 50 (1) 17-22;
  4. Gehlert, D R

    1. You have access
      Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;
  5. Geoghagen, N S

    1. You have access
      Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
      N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
      Molecular Pharmacology July 1996, 50 (1) 140-148;
  6. Gonzalez, F J

    1. You have access
      Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;
  7. Gorski, J C

    1. You have access
      Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;
  8. Grayson, D R

    1. You have access
      Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
      W J Zhu, J F Wang, S Vicini and D R Grayson
      Molecular Pharmacology July 1996, 50 (1) 23-33;
  9. Gribkoff, V K

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;
  10. Guerrero, S W

    1. You have access
      Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
      H Zhong, S W Guerrero, T A Esbenshade and K P Minneman
      Molecular Pharmacology July 1996, 50 (1) 175-184;
  11. Guzelian, P S

    1. You have access
      Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;

H

  1. Haehner, B D

    1. You have access
      Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;
  2. Hall, S D

    1. You have access
      Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;
  3. Hoffman, J A

    1. You have access
      Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

I

  1. Ikeda, H

    1. You have access
      mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
      M Yoshimura, H Ikeda and B Tabakoff
      Molecular Pharmacology July 1996, 50 (1) 43-51;

J

  1. Janardan, S K

    1. You have access
      Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;
  2. Johns, D G

    1. You have access
      2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
      G S Ahluwalia, W Y Gao, H Mitsuya and D G Johns
      Molecular Pharmacology July 1996, 50 (1) 160-165;

K

  1. Koesling, D

    1. You have access
      Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
      A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
      Molecular Pharmacology July 1996, 50 (1) 1-5;
  2. Kozlowski, E S

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

L

  1. Lakhlani, P P

    1. You have access
      Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling.
      P P Lakhlani, D M Lovinger and L E Limbird
      Molecular Pharmacology July 1996, 50 (1) 96-103;
  2. Larhammar, D

    1. You have access
      Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;
  3. Lee, N H

    1. You have access
      Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
      N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
      Molecular Pharmacology July 1996, 50 (1) 140-148;
  4. Lee, S S

    1. You have access
      Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;
  5. Leeb-Lundberg, L M

    1. You have access
      B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells.
      S A Mathis, N L Criscimagna and L M Leeb-Lundberg
      Molecular Pharmacology July 1996, 50 (1) 128-139;
  6. Limbird, L E

    1. You have access
      Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling.
      P P Lakhlani, D M Lovinger and L E Limbird
      Molecular Pharmacology July 1996, 50 (1) 96-103;
  7. Lin, Y F

    1. You have access
      Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
      Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 185-195;
  8. Linden, J

    1. You have access
      Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors.
      S Bhattacharya and J Linden
      Molecular Pharmacology July 1996, 50 (1) 104-111;
  9. Lovinger, D M

    1. You have access
      Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling.
      P P Lakhlani, D M Lovinger and L E Limbird
      Molecular Pharmacology July 1996, 50 (1) 96-103;
  10. Lum-Ragan, J T

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;
  11. Lundell, I

    1. You have access
      Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

M

  1. Macdonald, R L

    1. You have access
      Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
      E C Burgard, E I Tietz, T R Neelands and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 119-127;
    2. You have access
      Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
      Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 185-195;
  2. Marinozzi, M

    1. You have access
      (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
      C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
      Molecular Pharmacology July 1996, 50 (1) 6-9;
  3. Mathis, S A

    1. You have access
      B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells.
      S A Mathis, N L Criscimagna and L M Leeb-Lundberg
      Molecular Pharmacology July 1996, 50 (1) 128-139;
  4. Mayer, B

    1. You have access
      Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
      A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
      Molecular Pharmacology July 1996, 50 (1) 1-5;
  5. Mckay, M C

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;
  6. Meanwell, N A

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;
  7. Mesange, F

    1. You have access
      Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
      F Mesange, F Delarue, J Puel, F Bayard and J C Faye
      Molecular Pharmacology July 1996, 50 (1) 75-79;
  8. Mills, A S

    1. You have access
      Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;
  9. Minneman, K P

    1. You have access
      Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
      H Zhong, S W Guerrero, T A Esbenshade and K P Minneman
      Molecular Pharmacology July 1996, 50 (1) 175-184;
  10. Mitsuya, H

    1. You have access
      2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
      G S Ahluwalia, W Y Gao, H Mitsuya and D G Johns
      Molecular Pharmacology July 1996, 50 (1) 160-165;
  11. Monks, A

    1. You have access
      Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;
  12. Montali, J A

    1. You have access
      Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;
  13. Munson, P J

    1. You have access
      KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
      G E Rovati, R Shrager, S Nicosia and P J Munson
      Molecular Pharmacology July 1996, 50 (1) 86-95;
  14. Musco, S

    1. You have access
      Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

N

  1. Neelands, T R

    1. You have access
      Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
      E C Burgard, E I Tietz, T R Neelands and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 119-127;
  2. Nicoletti, F

    1. You have access
      (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
      C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
      Molecular Pharmacology July 1996, 50 (1) 6-9;
  3. Nicosia, S

    1. You have access
      KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
      G E Rovati, R Shrager, S Nicosia and P J Munson
      Molecular Pharmacology July 1996, 50 (1) 86-95;

P

  1. Pellicciari, R

    1. You have access
      (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
      C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
      Molecular Pharmacology July 1996, 50 (1) 6-9;
  2. Peters, J M

    1. You have access
      Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;
  3. Petralia, S

    1. You have access
      Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;
  4. Post-Munson, D J

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;
  5. Potenza, C

    1. You have access
      Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;
  6. Puel, J

    1. You have access
      Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
      F Mesange, F Delarue, J Puel, F Bayard and J C Faye
      Molecular Pharmacology July 1996, 50 (1) 75-79;

Q

  1. Quattrochi, L C

    1. You have access
      Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;

R

  1. Ram, P A

    1. You have access
      Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;
  2. Romine, J L

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;
  3. Rosser, D

    1. You have access
      Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;
  4. Rovati, G E

    1. You have access
      KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
      G E Rovati, R Shrager, S Nicosia and P J Munson
      Molecular Pharmacology July 1996, 50 (1) 86-95;
  5. Ruble, J

    1. You have access
      A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;

S

  1. Scammells, P J

    1. You have access
      A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;
  2. Schmidt, D E

    1. You have access
      Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;
  3. Schmidt, K

    1. You have access
      Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
      A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
      Molecular Pharmacology July 1996, 50 (1) 1-5;
  4. Schober, D A

    1. You have access
      Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;
  5. Schrammel, A

    1. You have access
      Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
      A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
      Molecular Pharmacology July 1996, 50 (1) 1-5;
  6. Sealfon, S C

    1. You have access
      Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
      N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
      Molecular Pharmacology July 1996, 50 (1) 34-42;
  7. Shrager, R

    1. You have access
      KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
      G E Rovati, R Shrager, S Nicosia and P J Munson
      Molecular Pharmacology July 1996, 50 (1) 86-95;
  8. Shryock, J C

    1. You have access
      A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;
  9. Simmons, M L

    1. You have access
      k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release.
      M L Simmons and C Chavkin
      Molecular Pharmacology July 1996, 50 (1) 80-85;
  10. Smiley, D L

    1. You have access
      Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;
  11. Srinivas, M

    1. You have access
      A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;
  12. Starrett, J E

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;
  13. Stivala, F

    1. You have access
      Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

T

  1. Tabakoff, B

    1. You have access
      mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
      M Yoshimura, H Ikeda and B Tabakoff
      Molecular Pharmacology July 1996, 50 (1) 43-51;
  2. Tew, K D

    1. You have access
      Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;
  3. Thomsen, C

    1. You have access
      (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
      C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
      Molecular Pharmacology July 1996, 50 (1) 6-9;
  4. Tietz, E I

    1. You have access
      Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
      E C Burgard, E I Tietz, T R Neelands and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 119-127;
  5. Travali, S

    1. You have access
      Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;
  6. Trojnacki, J T

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;
  7. Tukey, R H

    1. You have access
      Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;

V

  1. Vandenbranden, M

    1. You have access
      Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;
  2. Vázquez-Prado, J

    1. You have access
      Effect of phorbol myristate acetate on alpha 1-adrenergic action in cells expressing recombinant alpha 1-adrenoceptor subtypes.
      J Vázquez-Prado and J A García-Sáinz
      Molecular Pharmacology July 1996, 50 (1) 17-22;
  3. Ventra, C

    1. You have access
      Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;
  4. Vicini, S

    1. You have access
      Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
      W J Zhu, J F Wang, S Vicini and D R Grayson
      Molecular Pharmacology July 1996, 50 (1) 23-33;

W

  1. Wang, J F

    1. You have access
      Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
      W J Zhu, J F Wang, S Vicini and D R Grayson
      Molecular Pharmacology July 1996, 50 (1) 23-33;
  2. Watkins, P B

    1. You have access
      Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;
  3. Waxman, D J

    1. You have access
      Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;
  4. Weinstein, H

    1. You have access
      Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
      N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
      Molecular Pharmacology July 1996, 50 (1) 34-42;
  5. Wheatley, J B

    1. You have access
      Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;
  6. Witt-Enderby, P A

    1. You have access
      Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
      P A Witt-Enderby and M L Dubocovich
      Molecular Pharmacology July 1996, 50 (1) 166-174;
  7. Wrighton, S A

    1. You have access
      Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;

Y

  1. Yoshimura, M

    1. You have access
      mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
      M Yoshimura, H Ikeda and B Tabakoff
      Molecular Pharmacology July 1996, 50 (1) 43-51;

Z

  1. Zhong, H

    1. You have access
      Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
      H Zhong, S W Guerrero, T A Esbenshade and K P Minneman
      Molecular Pharmacology July 1996, 50 (1) 175-184;
  2. Zhong, J

    1. You have access
      Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;
  3. Zhou, Y C

    1. You have access
      Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;
  4. Zhu, W J

    1. You have access
      Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
      W J Zhu, J F Wang, S Vicini and D R Grayson
      Molecular Pharmacology July 1996, 50 (1) 23-33;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 50, Issue 1
1 Jul 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics